List of Tables
Table 1. Global COPD Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Bronchodilators
Table 3. Key Players of PDE-4 Inhibitors
Table 4. Key Players of Steroids
Table 5. Key Players of Combination Therapies
Table 6. Key Players of Others
Table 7. Global COPD Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global COPD Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global COPD Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global COPD Drugs Market Share by Region (2020-2025)
Table 11. Global COPD Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global COPD Drugs Market Share by Region (2026-2031)
Table 13. COPD Drugs Market Trends
Table 14. COPD Drugs Market Drivers
Table 15. COPD Drugs Market Challenges
Table 16. COPD Drugs Market Restraints
Table 17. Global COPD Drugs Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global COPD Drugs Market Share by Players (2020-2025)
Table 19. Global Top COPD Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in COPD Drugs as of 2024)
Table 20. Ranking of Global Top COPD Drugs Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by COPD Drugs Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of COPD Drugs, Headquarters and Area Served
Table 23. Global Key Players of COPD Drugs, Product and Application
Table 24. Global Key Players of COPD Drugs, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global COPD Drugs Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global COPD Drugs Revenue Market Share by Type (2020-2025)
Table 28. Global COPD Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global COPD Drugs Revenue Market Share by Type (2026-2031)
Table 30. Global COPD Drugs Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global COPD Drugs Revenue Market Share by Application (2020-2025)
Table 32. Global COPD Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global COPD Drugs Revenue Market Share by Application (2026-2031)
Table 34. North America COPD Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America COPD Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America COPD Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe COPD Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe COPD Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe COPD Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific COPD Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific COPD Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific COPD Drugs Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America COPD Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America COPD Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America COPD Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa COPD Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa COPD Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa COPD Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 49. Pfizer Company Details
Table 50. Pfizer Business Overview
Table 51. Pfizer COPD Drugs Product
Table 52. Pfizer Revenue in COPD Drugs Business (2020-2025) & (US$ Million)
Table 53. Pfizer Recent Development
Table 54. Novartis Company Details
Table 55. Novartis Business Overview
Table 56. Novartis COPD Drugs Product
Table 57. Novartis Revenue in COPD Drugs Business (2020-2025) & (US$ Million)
Table 58. Novartis Recent Development
Table 59. GlaxoSmithKline Company Details
Table 60. GlaxoSmithKline Business Overview
Table 61. GlaxoSmithKline COPD Drugs Product
Table 62. GlaxoSmithKline Revenue in COPD Drugs Business (2020-2025) & (US$ Million)
Table 63. GlaxoSmithKline Recent Development
Table 64. Merck Company Details
Table 65. Merck Business Overview
Table 66. Merck COPD Drugs Product
Table 67. Merck Revenue in COPD Drugs Business (2020-2025) & (US$ Million)
Table 68. Merck Recent Development
Table 69. Abbott Laboratories Company Details
Table 70. Abbott Laboratories Business Overview
Table 71. Abbott Laboratories COPD Drugs Product
Table 72. Abbott Laboratories Revenue in COPD Drugs Business (2020-2025) & (US$ Million)
Table 73. Abbott Laboratories Recent Development
Table 74. Boehringer Ingelheim Company Details
Table 75. Boehringer Ingelheim Business Overview
Table 76. Boehringer Ingelheim COPD Drugs Product
Table 77. Boehringer Ingelheim Revenue in COPD Drugs Business (2020-2025) & (US$ Million)
Table 78. Boehringer Ingelheim Recent Development
Table 79. AstraZeneca Company Details
Table 80. AstraZeneca Business Overview
Table 81. AstraZeneca COPD Drugs Product
Table 82. AstraZeneca Revenue in COPD Drugs Business (2020-2025) & (US$ Million)
Table 83. AstraZeneca Recent Development
Table 84. Roche Holding AG Company Details
Table 85. Roche Holding AG Business Overview
Table 86. Roche Holding AG COPD Drugs Product
Table 87. Roche Holding AG Revenue in COPD Drugs Business (2020-2025) & (US$ Million)
Table 88. Roche Holding AG Recent Development
Table 89. Teva Pharmaceutical Industries Company Details
Table 90. Teva Pharmaceutical Industries Business Overview
Table 91. Teva Pharmaceutical Industries COPD Drugs Product
Table 92. Teva Pharmaceutical Industries Revenue in COPD Drugs Business (2020-2025) & (US$ Million)
Table 93. Teva Pharmaceutical Industries Recent Development
Table 94. Vectura Group Company Details
Table 95. Vectura Group Business Overview
Table 96. Vectura Group COPD Drugs Product
Table 97. Vectura Group Revenue in COPD Drugs Business (2020-2025) & (US$ Million)
Table 98. Vectura Group Recent Development
Table 99. Mylan NV Company Details
Table 100. Mylan NV Business Overview
Table 101. Mylan NV COPD Drugs Product
Table 102. Mylan NV Revenue in COPD Drugs Business (2020-2025) & (US$ Million)
Table 103. Mylan NV Recent Development
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
Table 107. Authors List of This Report
List of Figures
Figure 1. COPD Drugs Picture
Figure 2. Global COPD Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global COPD Drugs Market Share by Type: 2024 VS 2031
Figure 4. Bronchodilators Features
Figure 5. PDE-4 Inhibitors Features
Figure 6. Steroids Features
Figure 7. Combination Therapies Features
Figure 8. Others Features
Figure 9. Global COPD Drugs Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global COPD Drugs Market Share by Application: 2024 VS 2031
Figure 11. Hospitals Case Studies
Figure 12. Clinics Case Studies
Figure 13. Others Case Studies
Figure 14. COPD Drugs Report Years Considered
Figure 15. Global COPD Drugs Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global COPD Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global COPD Drugs Market Share by Region: 2024 VS 2031
Figure 18. Global COPD Drugs Market Share by Players in 2024
Figure 19. Global Top COPD Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in COPD Drugs as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by COPD Drugs Revenue in 2024
Figure 21. North America COPD Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America COPD Drugs Market Share by Country (2020-2031)
Figure 23. United States COPD Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada COPD Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe COPD Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe COPD Drugs Market Share by Country (2020-2031)
Figure 27. Germany COPD Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France COPD Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. COPD Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy COPD Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia COPD Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries COPD Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific COPD Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific COPD Drugs Market Share by Region (2020-2031)
Figure 35. China COPD Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan COPD Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea COPD Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia COPD Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India COPD Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia COPD Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America COPD Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America COPD Drugs Market Share by Country (2020-2031)
Figure 43. Mexico COPD Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil COPD Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa COPD Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa COPD Drugs Market Share by Country (2020-2031)
Figure 47. Turkey COPD Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia COPD Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE COPD Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Pfizer Revenue Growth Rate in COPD Drugs Business (2020-2025)
Figure 51. Novartis Revenue Growth Rate in COPD Drugs Business (2020-2025)
Figure 52. GlaxoSmithKline Revenue Growth Rate in COPD Drugs Business (2020-2025)
Figure 53. Merck Revenue Growth Rate in COPD Drugs Business (2020-2025)
Figure 54. Abbott Laboratories Revenue Growth Rate in COPD Drugs Business (2020-2025)
Figure 55. Boehringer Ingelheim Revenue Growth Rate in COPD Drugs Business (2020-2025)
Figure 56. AstraZeneca Revenue Growth Rate in COPD Drugs Business (2020-2025)
Figure 57. Roche Holding AG Revenue Growth Rate in COPD Drugs Business (2020-2025)
Figure 58. Teva Pharmaceutical Industries Revenue Growth Rate in COPD Drugs Business (2020-2025)
Figure 59. Vectura Group Revenue Growth Rate in COPD Drugs Business (2020-2025)
Figure 60. Mylan NV Revenue Growth Rate in COPD Drugs Business (2020-2025)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
